» Articles » PMID: 27631363

EPGA: A Web-Based Information System for Translational Pharmacogenomics

Overview
Journal PLoS One
Date 2016 Sep 16
PMID 27631363
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

One of the challenges that arise from the advent of personal genomics services is to efficiently couple individual data with state of the art Pharmacogenomics (PGx) knowledge. Existing services are limited to either providing static views of PGx variants or applying a simplistic match between individual genotypes and existing PGx variants. Moreover, there is a considerable amount of haplotype variation associated with drug metabolism that is currently insufficiently addressed. Here, we present a web-based electronic Pharmacogenomics Assistant (ePGA; http://www.epga.gr/) that provides personalized genotype-to-phenotype translation, linked to state of the art clinical guidelines. ePGA's translation service matches individual genotype-profiles with PGx gene haplotypes and infers the corresponding diplotype and phenotype profiles, accompanied with summary statistics. Additional features include i) the ability to customize translation based on subsets of variants of clinical interest, and ii) to update the knowledge base with novel PGx findings. We demonstrate ePGA's functionality on genetic variation data from the 1000 Genomes Project.

Citing Articles

Pharmacogenomics Tools for Precision Public Health and Lessons for Low- and Middle-Income Countries: A Scoping Review.

Borbon A, Briceno J, Valderrama-Aguirre A Pharmgenomics Pers Med. 2025; 18:19-34.

PMID: 39902237 PMC: 11789506. DOI: 10.2147/PGPM.S490135.


Advancing Nursing Research Through Interactive Data Visualization With R Shiny.

Heinsberg L, Koleck T, Ray M, Weeks D, Conley Y Biol Res Nurs. 2022; 25(1):107-116.

PMID: 36029021 PMC: 9900251. DOI: 10.1177/10998004221121109.


PharmVIP: A Web-Based Tool for Pharmacogenomic Variant Analysis and Interpretation.

Piriyapongsa J, Sukritha C, Kaewprommal P, Intarat C, Triparn K, Phornsiricharoenphant K J Pers Med. 2021; 11(11).

PMID: 34834582 PMC: 8618518. DOI: 10.3390/jpm11111230.


Host pharmacogenetic factors that may affect liver neoplasm incidence upon using direct-acting antivirals for treating hepatitis C infection.

Zidan A, Saad E, Ibrahim N, Hashem M, Mahmoud A, Hemeida A Heliyon. 2021; 7(5):e06908.

PMID: 34013078 PMC: 8113831. DOI: 10.1016/j.heliyon.2021.e06908.


EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection.

Postigo R, Brosch S, Slattery J, van Haren A, Dogne J, Kurz X Drug Saf. 2018; 41(7):665-675.

PMID: 29520645 PMC: 5990579. DOI: 10.1007/s40264-018-0647-1.


References
1.
Ritchie M . The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era. Hum Genet. 2012; 131(10):1615-26. PMC: 3432217. DOI: 10.1007/s00439-012-1221-z. View

2.
Mette L, Mitropoulos K, Vozikis A, Patrinos G . Pharmacogenomics and public health: implementing 'populationalized' medicine. Pharmacogenomics. 2012; 13(7):803-13. DOI: 10.2217/pgs.12.52. View

3.
Motsinger-Reif A, Jorgenson E, Relling M, Kroetz D, Weinshilboum R, Cox N . Genome-wide association studies in pharmacogenomics: successes and lessons. Pharmacogenet Genomics. 2010; 23(8):383-94. PMC: 3003940. DOI: 10.1097/FPC.0b013e32833d7b45. View

4.
Dalabira E, Viennas E, Daki E, Komianou A, Bartsakoulia M, Poulas K . DruGeVar: an online resource triangulating drugs with genes and genomic biomarkers for clinical pharmacogenomics. Public Health Genomics. 2014; 17(5-6):265-71. DOI: 10.1159/000365895. View

5.
Mitropoulou C, Mai Y, van Schaik R, Vozikis A, Patrinos G . Stakeholder analysis in pharmacogenomics and genomic medicine in Greece. Public Health Genomics. 2014; 17(5-6):280-6. DOI: 10.1159/000365896. View